Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl− efflux signaling pathway

Zhen Zhang,Shujun Xie,Jin Qian,Fengqiang Gao,Wenjian Jin,Lingqiao Wang,Lili Yan,Hao Chen,Wangxiang Yao,Maoqiang Li,Xuepeng Wang,Liulong Zhu
DOI: https://doi.org/10.1186/s12967-023-04313-1
IF: 8.44
2023-07-10
Journal of Translational Medicine
Abstract:Osteoarthritis (OA), in which macrophage-driven synovitis is considered closely related to cartilage destruction and could occur at any stage, is an inflammatory arthritis. However, there are no effective targets to cure the progression of OA. The NOD-, LRR-,and pyrin domain-containing protein 3 (NLRP3) inflammasome in synovial macrophages participates in the pathological inflammatory process and treatment strategies targeting it are considered to be an effective approach for OA. PIM-1 kinase, as a downstream effector of many cytokine signaling pathways, plays a pro-inflammatory role in inflammatory disease.
medicine, research & experimental
What problem does this paper attempt to address?